Lucy Scientific Discovery Inc.
LSDI · NASDAQ
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Revenue | $10 | $0 | $7 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $23 | $47 | $32 | $27 |
| Gross Profit | -$13 | -$47 | -$25 | -$27 |
| % Margin | -138.3% | – | -358.6% | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $849 | $1,510 | $2,103 | $2,388 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $849 | $1,510 | $2,103 | $2,388 |
| Operating Income | -$863 | -$1,607 | -$2,100 | -$2,388 |
| % Margin | -8,906.5% | – | -29,799.1% | – |
| Other Income/Exp. Net | -$441 | -$391 | -$477 | -$1,718 |
| Pre-Tax Income | -$1,304 | -$1,998 | -$2,577 | -$4,106 |
| Tax Expense | $1,507 | $0 | $0 | $1,182 |
| Net Income | -$2,811 | -$1,998 | -$2,577 | -$5,288 |
| % Margin | -29,028% | – | -36,565% | – |
| EPS | -0.16 | -0.11 | -0.15 | -0.39 |
| % Growth | -45.5% | 26.7% | 61.5% | – |
| EPS Diluted | -0.16 | -0.11 | -0.15 | -0.39 |
| Weighted Avg Shares Out | 17,646 | 17,581 | 17,206 | 13,634 |
| Weighted Avg Shares Out Dil | 17,646 | 17,581 | 17,206 | 13,634 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $402 | $536 |
| Interest Expense | $128 | $391 | $402 | $536 |
| Depreciation & Amortization | $19 | $47 | $28 | $27 |
| EBITDA | -$1,156 | -$1,657 | -$2,147 | -$3,543 |
| % Margin | -11,937.9% | – | -30,466.2% | – |